Pfizer in Boston

The giant pharmaceutical company Pfizer already has partnerships with academic medical centers in San Francisco and New York City. Now they’re adding Boston. According to a press release, the company will house its Center for Therapeutic Innovation in the Longwood area and invest $100 million over five years to bring basic science discoveries to clinical applications.

The semi-autonomous center will be headed by a Pfizer scientist but draw postdocs from academic medical centers. A brochure describes that faculty from academic medical centers will be involved on a steering committee that helps decide projects and monitors conflicts of interest. Important to note in light of a recent U.S. Supreme Court decision involving a Stanford biomedical researcher, Pfizer retains first right to license any clinical probes that come out of the research.

This entry was posted
on Thursday, June 9th, 2011 at 9:06 am and is filed under Faculty development.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.